-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
المؤلفون: Le Moigne R; Cleave Biosciences, Inc., Burlingame, California. ronan.lemoigne29@gmail.com., Aftab BT; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., Djakovic S; Cleave Biosciences, Inc., Burlingame, California., Dhimolea E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Valle E; Cleave Biosciences, Inc., Burlingame, California., Murnane M; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., King EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Soriano F; Cleave Biosciences, Inc., Burlingame, California., Menon MK; Cleave Biosciences, Inc., Burlingame, California., Wu ZY; Cleave Biosciences, Inc., Burlingame, California., Wong ST; Cleave Biosciences, Inc., Burlingame, California., Lee GJ; Cleave Biosciences, Inc., Burlingame, California., Yao B; Cleave Biosciences, Inc., Burlingame, California., Wiita AP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California., Lam C; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California., Rice J; Cleave Biosciences, Inc., Burlingame, California., Wang J; Cleave Biosciences, Inc., Burlingame, California., Chesi M; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona., Bergsagel PL; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona., Kraus M; Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen, Switzerland., Driessen C; Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen, Switzerland., Kiss von Soly S; Cleave Biosciences, Inc., Burlingame, California., Yakes FM; Cleave Biosciences, Inc., Burlingame, California., Wustrow D; Cleave Biosciences, Inc., Burlingame, California., Shawver L; Cleave Biosciences, Inc., Burlingame, California., Zhou HJ; Cleave Biosciences, Inc., Burlingame, California., Martin TG 3rd; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., Wolf JL; Department of Medicine, Division of Hematology & Oncology, University of California San Francisco, San Francisco, California., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Anderson DJ; Cleave Biosciences, Inc., Burlingame, California., Rolfe M; Cleave Biosciences, Inc., Burlingame, California.
المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2017 Nov; Vol. 16 (11), pp. 2375-2386. Date of Electronic Publication: 2017 Sep 06.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
مواضيع طبية MeSH: Adenosine Triphosphatases/*genetics , Indoles/*administration & dosage , Multiple Myeloma/*drug therapy , Nuclear Proteins/*genetics , Nuclear Respiratory Factor 1/*genetics , Proteasome Inhibitors/*administration & dosage , Pyrimidines/*administration & dosage, Adenosine Triphosphatases/antagonists & inhibitors ; Animals ; Apoptosis/drug effects ; Cell Proliferation/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mice ; Multiple Myeloma/genetics ; Multiple Myeloma/pathology ; Nuclear Proteins/antagonists & inhibitors ; Proteasome Endopeptidase Complex/drug effects ; Ubiquitin/genetics ; Unfolded Protein Response/drug effects ; Xenograft Model Antitumor Assays